Publications by authors named "J R Gonzalez Juanatey"
Open window mapping with extended early meets late algorithm vs. conventional mapping for accessory pathway ablation.
J Interv Card Electrophysiol
December 2024
Background: Catheter ablation of accessory pathway is the treatment of choice for patients with symptomatic Wolff-Parkinson-White (WPW) syndrome. Accessory pathway (AP) identification relies on point-by-point mapping, raising the need for more precise and efficient methods. High-density open window mapping (OWM) combined with the extended early meets late (EEML) algorithm, utilizing 3D electroanatomic mapping systems, is a promising alternative.
View Article and Find Full Text PDFArticle Synopsis
- Cardiogenic shock (CS) is a serious condition with significant mortality, prompting a study to create a risk score to predict in-hospital death in affected patients.
- A retrospective analysis of 135 patients identified key factors—like age, mitral regurgitation, and certain biomarkers—that contributed to the development of the Santiago Shock Score (S3), which showed a high accuracy for predicting mortality (AUC 0.85).
- The S3 score categorizes patients into low, intermediate, and high-risk groups with respective mortality rates of 12.9%, 49.1%, and 87.5%, providing a tool for better risk assessment and treatment decisions for patients with CS.
Antithrombotic Strategy in Secondary Prevention for High-Risk Patients with Previous Acute Coronary Syndrome: Overlap between the PEGASUS Eligibility and the COMPASS Eligibility in a Large Multicenter Registry.
Am J Cardiovasc Drugs
January 2023
Article Synopsis
- Patients with a history of acute coronary syndrome (ACS) have a high risk of recurring cardiovascular issues, and recent therapies aim to lower these risks but may increase bleeding.
- In a study of over 10,000 ACS patients, it was found that 53.4% qualified for the PEGASUS strategy, while 38.2% were eligible for the COMPASS strategy, with a notable overlap of 34.4% between the two.
- Overall, about one-third of the patients could benefit from either prolonged dual antiplatelet therapy or dual pathway inhibition, indicating varying eligibility for these treatments among ACS patients.
Influenza Vaccination for the Prevention of Cardiovascular Disease in the Americas: Consensus document of the Inter-American Society of Cardiology and the Word Heart Federation.
Glob Heart
October 2021
Background: Cardiovascular mortality is decreasing but remains the leading cause of death world-wide. Respiratory infections such as influenza significantly contribute to morbidity and mortality in patients with cardiovascular disease. Despite of proven benefits, influenza vaccination is not fully implemented, especially in Latin America.
View Article and Find Full Text PDFTelemedicine (TM) is potentially a way of escalating heart failure (HF) multidisciplinary integrated care. Despite the initial efforts to implement TM in HF management, we are still at an early stage of its implementation. The coronavirus disease 2019 pandemic led to an increased utilisation of TM.
View Article and Find Full Text PDF